Federal Comment Calendar
Federal comment dates for Food and Drug Administration
45 listed events across 45 Federal Register notices.
Download these calendar remindersBrowse notices by date
-
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device TrackingFood and Drug Administration · Document 2026-18529 · FDA-2026-N-9350 -
Hearing ·
Use of Salt Substitutes To Reduce the Sodium Content in Standardized FoodsFood and Drug Administration · Document 2026-20848 · FDA-2022-N-2226 -
Comments due ·
Statistical Considerations for the Design of Rare Disease Clinical Investigations; Establishment of a Public Docket; Request for Information and CommentsFood and Drug Administration · Document 2026-18805 · FDA-2026-N-10165 -
Hearing ·
Food Additives Permitted in Feed and Drinking Water of Animals; Chromium PropionateFood and Drug Administration · Document 2026-20979 · FDA-2026-F-2048 -
Comments due ·
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Infant Formula RequirementsFood and Drug Administration · Document 2026-20980 · FDA-2026-N-7131 -
Comments due ·
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary National Retail Food Regulatory Program StandardsFood and Drug Administration · Document 2026-20981 · FDA-2026-N-7338 -
Comments due ·
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Requirements for Cosmetic ProductsFood and Drug Administration · Document 2026-20990 · FDA-2026-N-6739 -
Comments due ·
Target Animal Safety Evaluation for Veterinary Monoclonal Antibody Products; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-19141 · FDA-2026-D-7233 -
Comments due ·
Biosimilar User Fee Act III Future Needs in the Development of Interchangeable Products Post-Workshop; Draft Strategy DocumentFood and Drug Administration · Document 2026-19166 · FDA-2025-N-2787 -
Comments due ·
Electronic Submission Template for Medical Device Premarket Approval Applications (PMAs); Draft Guidance for Industry and Food and Drug Administration Staff; AvailabilityFood and Drug Administration · Document 2026-19181 · FDA-2026-D-9429 -
Comments due ·
Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-16960 · FDA-2026-D-8561 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002Food and Drug Administration · Document 2026-19281 · FDA-2026-N-10033 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; State Petitions for Exemption From PreemptionFood and Drug Administration · Document 2026-19282 · FDA-2026-N-10430 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Temporary Marketing Permit ApplicationsFood and Drug Administration · Document 2026-19283 · FDA-2026-N-10363 -
Comments due ·
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for InformationFood and Drug Administration · Document 2026-20427 · FDA-2026-N-10429 -
Comments due ·
Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-20721 · FDA-2025-D-6952 -
Comments due ·
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accreditation Scheme for Conformity Assessment ProgramFood and Drug Administration · Document 2026-21712 · FDA-2026-N-7130 -
Comments due ·
Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; AvailabilityFood and Drug Administration · Document 2026-19704 · FDA-2026-N-9505 -
Comments due ·
Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for CommentsFood and Drug Administration · Document 2026-19660 · FDA-2015-N-3326 -
Comments due ·
Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment RequestFood and Drug Administration · Document 2026-17580 · FDA-2018-D-4533 -
Comments due ·
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Color Additive CertificationFood and Drug Administration · Document 2026-21913 · FDA-2026-N-2742 -
Comments due ·
Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-21954 · FDA-2026-D-11783 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review BoardsFood and Drug Administration · Document 2026-19849 · FDA-2026-N-10132 -
Comments due ·
Pharmacokinetics in Patients With Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosage; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-17961 · FDA-2026-D-8693 -
Comments due ·
Challenges and Solutions in Lot-Level Food Traceability; Public MeetingFood and Drug Administration · Document 2026-20720 · FDA-2014-N-0053 -
Comments due ·
Nonclinical Testing TerminologyFood and Drug Administration · Document 2026-19349 · FDA-2026-N-5347 -
Comments due ·
Nonclinical Testing TerminologyFood and Drug Administration · Document 2026-19350 · FDA-2026-N-5347 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency Pursuant to Dietary Risk ConsiderationsFood and Drug Administration · Document 2026-20663 · FDA-2026-N-10605 -
Comments due ·
Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRICFood and Drug Administration · Document 2026-20766 -
Comments due ·
Substances Generally Recognized as SafeFood and Drug Administration · Document 2026-16296 · FDA-2025-N-3262 -
Hearing ·
Color Additive Petition From Environmental Defense Fund et al.; Request To Amend the Color Additive Regulations To Remove the Solvents Ethylene Dichloride, Methylene Chloride, and TrichloroethyleneFood and Drug Administration · Document 2026-22865 · FDA-2023-C-5679 -
Hearing ·
Color Additive Petition From the International Association of Color Manufacturers; Request To Amend the Color Additive Regulations To Remove the Solvents Methylene Chloride, Trichloroethylene, and Ethylene DichlorideFood and Drug Administration · Document 2026-22866 · FDA-2026-C-3071 -
Comments due ·
Fit-for-Purpose Rare Disease Framework Initiative; Public Meeting; Request for Information and CommentsFood and Drug Administration · Document 2026-21142 · FDA-2026-N-12214 -
Comments due ·
Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-21670 · FDA-2025-D-4023 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Product Jurisdiction and Combination ProductsFood and Drug Administration · Document 2026-21713 · FDA-2026-N-11261 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Export Certificates for FDA Regulated ProductsFood and Drug Administration · Document 2026-21714 · FDA-2026-N-11074 -
Comments due ·
U.S.-Origin Statements on Seafood; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-21838 · FDA-2026-D-6729 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Records; Electronic SignaturesFood and Drug Administration · Document 2026-21908 · FDA-2023-N-3743 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Rapid Response SurveysFood and Drug Administration · Document 2026-21912 · FDA-2026-N-11623 -
Comments due ·
Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Participation in Food and Drug Administration Fellowship and Traineeship ProgramsFood and Drug Administration · Document 2026-21914 · FDA-2026-N-11301 -
Comments due ·
Electronic Submission Template for Investigational Device Exemption (IDE) Applications; Draft Guidance for Sponsors and Food and Drug Administration Staff; AvailabilityFood and Drug Administration · Document 2026-21953 · FDA-2026-D-11188 -
Comments due ·
FDA Rare Disease Innovation Hub Future Programming; Request for CommentsFood and Drug Administration · Document 2026-01903 · FDA-2026-N-0131 -
Comments due ·
Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-21669 · FDA-2016-D-2343 -
Comments due ·
Essential Drug Delivery Performance Characteristics for Devices Intended To Deliver Drugs and Biological Products; Revised Draft Guidance for Industry; AvailabilityFood and Drug Administration · Document 2026-22203 · FDA-2024-D-2560 -
Comments due ·
Infant Formula Nutrient RequirementsFood and Drug Administration · Document 2026-22273 · FDA-2026-N-10832
How the dates were read
Follow the notice before filing
This calendar reads dated events in the Federal Register’s DATES notes. The snapshot includes future dates found in the Register’s date query and a review of notices published in the prior 120 days. It was checked on November 10, 2026.
- Initial comments, replies, hearings, and requests for hearings appear separately when the notice supplies distinct dates. Some notices need a separate deadline calculation or an agency portal, so coverage varies.
- We link changed deadlines when an explicit revision matches an earlier notice by docket, agency and subject. The comparison pairs the same phase and counts calendar days between the two dates.
- Calendar files include an exact time when the note identifies a recognizable time zone. Other entries carry the printed date as an all-day reminder. Follow the notice for any filing instructions and later changes.
Federal Register data documentation · Regulations.gov · Download this snapshot